Experience across a range of drug delivery platforms including dry powder inhalers (DPIs) and solutions/suspensions for inhalation.
Watch our video
Inhaled drug development
Quotient has a 30 year track record in the development and manufacturing of inhaled drug products. We have experience across a range of drug delivery platforms including dry powder inhalers (DPIs) and solutions/suspensions for inhalation.
With integrated capabilities and vast knowledge of nasal and pulmonary delivery, we help our clients accelerate their molecules from first-in-human, through to proof-of-concept and into full development.